About this trial
This prospective, randomized, patient- and assessor-blinded, single-center non-inferiority trial will compare the analgesic efficacy of the Shoulder Posterior Pericapsular Nerve Group (SPENG) block with combined posterior suprascapular and axillary nerve blocks in adults undergoing elective shoulder arthroscopy under general anesthesia. Both groups will receive the same total volume and concentration of local anesthetic. The primary outcome will be the highest resting Numeric Rating Scale pain score recorded during the first 24 postoperative hours. Secondary outcomes will include block performance time, sensory block success in suprascapular and axillary nerve territories, opioid consumption, time to rescue analgesia, motor function, diaphragmatic function, postoperative recovery quality, patient satisfaction, and block-related complications.
Eligibility criteria
Qualifiers
Age 18 to 70 years
American Society of Anesthesiologists (ASA) physical status I-III
Scheduled to undergo elective shoulder arthroscopy under general anesthesia
Able to understand the Numeric Rating Scale for pain assessment
Disqualifiers
Known allergy or hypersensitivity to local anesthetics used in the study
Infection at the planned block injection site
Coagulopathy or ongoing anticoagulant therapy that cannot be appropriately interrupted for peripheral nerve block
Pre-existing neurological deficit affecting the operative upper extremity
Trial design
Treatments tested in this trial
- Shoulder Posterior Pericapsular Nerve Group (SPENG) Block
- Combined Posterior Suprascapular and Axillary Nerve Blocks